Cargando…

Effects of Adherence to Pharmacological Treatment on the Recovery of Patients with Schizophrenia

The aim of this study was to evaluate the effects of adherence to antipsychotic treatment on the recovery of patients with schizophrenia in northern Chile. One hundred and fifty-one patients diagnosed with schizophrenia completed the Drug Attitude Inventory (DAI-10), Positive and Negative Syndrome S...

Descripción completa

Detalles Bibliográficos
Autores principales: Caqueo-Urízar, Alejandra, Urzúa, Alfonso, Mena-Chamorro, Patricio, Bravo de la Fuente, Josefa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468521/
https://www.ncbi.nlm.nih.gov/pubmed/34575005
http://dx.doi.org/10.3390/healthcare9091230
_version_ 1784573691437252608
author Caqueo-Urízar, Alejandra
Urzúa, Alfonso
Mena-Chamorro, Patricio
Bravo de la Fuente, Josefa
author_facet Caqueo-Urízar, Alejandra
Urzúa, Alfonso
Mena-Chamorro, Patricio
Bravo de la Fuente, Josefa
author_sort Caqueo-Urízar, Alejandra
collection PubMed
description The aim of this study was to evaluate the effects of adherence to antipsychotic treatment on the recovery of patients with schizophrenia in northern Chile. One hundred and fifty-one patients diagnosed with schizophrenia completed the Drug Attitude Inventory (DAI-10), Positive and Negative Syndrome Scale for Schizophrenia (PANSS), Recovery Assessment Scale (RAS-24), sociodemographic information, and clinical and treatment characteristics of patients with schizophrenia. Multivariate analysis with multiple linear regression was then performed to identify variables that were potentially associated with the recovery assessment (variable criterion). A significant association was found between adherence to antipsychotic medication and the Willing to Ask for Help dimension of Recovery (β = 0.239, p = 0.005). Association of clinical and socio-demographic variables with recovery were identified: negative symptoms with Personal Confidence and Hope (β = −0.341, p = 0.001) and Goal and Success Orientation (β = −0.266, p = 0.014); cognitive symptoms with Willing to Ask for Help (β = −0.305, p = 0.018) and no domination by symptoms (β = −0.351, p = 0.005); marital status with reliance on others (β = −0.181, p = 0.045); age with Personal Confidence and Hope (β = −0.217, p = 0.021), Goal and Success Orientation (β = −0.296, p = 0.003), and no domination by symptoms (β = 0.214, p = 0.025). Adherence has a positive relationship with personal recovery in this sample of Chilean patients with schizophrenia.
format Online
Article
Text
id pubmed-8468521
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84685212021-09-27 Effects of Adherence to Pharmacological Treatment on the Recovery of Patients with Schizophrenia Caqueo-Urízar, Alejandra Urzúa, Alfonso Mena-Chamorro, Patricio Bravo de la Fuente, Josefa Healthcare (Basel) Article The aim of this study was to evaluate the effects of adherence to antipsychotic treatment on the recovery of patients with schizophrenia in northern Chile. One hundred and fifty-one patients diagnosed with schizophrenia completed the Drug Attitude Inventory (DAI-10), Positive and Negative Syndrome Scale for Schizophrenia (PANSS), Recovery Assessment Scale (RAS-24), sociodemographic information, and clinical and treatment characteristics of patients with schizophrenia. Multivariate analysis with multiple linear regression was then performed to identify variables that were potentially associated with the recovery assessment (variable criterion). A significant association was found between adherence to antipsychotic medication and the Willing to Ask for Help dimension of Recovery (β = 0.239, p = 0.005). Association of clinical and socio-demographic variables with recovery were identified: negative symptoms with Personal Confidence and Hope (β = −0.341, p = 0.001) and Goal and Success Orientation (β = −0.266, p = 0.014); cognitive symptoms with Willing to Ask for Help (β = −0.305, p = 0.018) and no domination by symptoms (β = −0.351, p = 0.005); marital status with reliance on others (β = −0.181, p = 0.045); age with Personal Confidence and Hope (β = −0.217, p = 0.021), Goal and Success Orientation (β = −0.296, p = 0.003), and no domination by symptoms (β = 0.214, p = 0.025). Adherence has a positive relationship with personal recovery in this sample of Chilean patients with schizophrenia. MDPI 2021-09-18 /pmc/articles/PMC8468521/ /pubmed/34575005 http://dx.doi.org/10.3390/healthcare9091230 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Caqueo-Urízar, Alejandra
Urzúa, Alfonso
Mena-Chamorro, Patricio
Bravo de la Fuente, Josefa
Effects of Adherence to Pharmacological Treatment on the Recovery of Patients with Schizophrenia
title Effects of Adherence to Pharmacological Treatment on the Recovery of Patients with Schizophrenia
title_full Effects of Adherence to Pharmacological Treatment on the Recovery of Patients with Schizophrenia
title_fullStr Effects of Adherence to Pharmacological Treatment on the Recovery of Patients with Schizophrenia
title_full_unstemmed Effects of Adherence to Pharmacological Treatment on the Recovery of Patients with Schizophrenia
title_short Effects of Adherence to Pharmacological Treatment on the Recovery of Patients with Schizophrenia
title_sort effects of adherence to pharmacological treatment on the recovery of patients with schizophrenia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468521/
https://www.ncbi.nlm.nih.gov/pubmed/34575005
http://dx.doi.org/10.3390/healthcare9091230
work_keys_str_mv AT caqueourizaralejandra effectsofadherencetopharmacologicaltreatmentontherecoveryofpatientswithschizophrenia
AT urzuaalfonso effectsofadherencetopharmacologicaltreatmentontherecoveryofpatientswithschizophrenia
AT menachamorropatricio effectsofadherencetopharmacologicaltreatmentontherecoveryofpatientswithschizophrenia
AT bravodelafuentejosefa effectsofadherencetopharmacologicaltreatmentontherecoveryofpatientswithschizophrenia